Your browser doesn't support javascript.
loading
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting.
Julg, Boris; Dee, Lynda; Ananworanich, Jintanat; Barouch, Dan H; Bar, Katharine; Caskey, Marina; Colby, Donn J; Dawson, Liza; Dong, Krista L; Dubé, Karine; Eron, Joseph; Frater, John; Gandhi, Rajesh T; Geleziunas, Romas; Goulder, Philip; Hanna, George J; Jefferys, Richard; Johnston, Rowena; Kuritzkes, Daniel; Li, Jonathan Z; Likhitwonnawut, Udom; van Lunzen, Jan; Martinez-Picado, Javier; Miller, Veronica; Montaner, Luis J; Nixon, Douglas F; Palm, David; Pantaleo, Giuseppe; Peay, Holly; Persaud, Deborah; Salzwedel, Jessica; Salzwedel, Karl; Schacker, Timothy; Sheikh, Virginia; Søgaard, Ole S; Spudich, Serena; Stephenson, Kathryn; Sugarman, Jeremy; Taylor, Jeff; Tebas, Pablo; Tiemessen, Caroline T; Tressler, Randall; Weiss, Carol D; Zheng, Lu; Robb, Merlin L; Michael, Nelson L; Mellors, John W; Deeks, Steven G; Walker, Bruce D.
Afiliación
  • Julg B; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; Infectious Disease Division, Massachusetts General Hospital, Boston, MA, USA. Electronic address: bjulg@mgh.harvard.edu.
  • Dee L; AIDS Action Baltimore, Baltimore, MD, USA.
  • Ananworanich J; US Military HIV Research Program, Henry Jackson Foundation, Bethesda, MD, USA.
  • Barouch DH; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Bar K; Department of Medicine, University of Pennsylvania, Pennsylvania, PA, USA.
  • Caskey M; Laboratory of Molecular Immunology, Rockefeller University, New York, NY, USA.
  • Colby DJ; Thai Red Cross AIDS Research Center, Bangkok, Thailand.
  • Dawson L; National Institute of Allergy and Infectious Diseases, Fishers ln Rockville, MD, USA.
  • Dong KL; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; University of KwaZulu Natal, Durban, South Africa.
  • Dubé K; Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.
  • Eron J; Division of Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA.
  • Frater J; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Oxford National Institute of Health Research Biomedical Research Centre, Oxford, UK.
  • Gandhi RT; Infectious Disease Division, Massachusetts General Hospital, Boston, MA, USA.
  • Geleziunas R; Gilead Sciences, Foster City, CA, USA.
  • Goulder P; Department of Paediatrics, University of Oxford, Oxford, UK.
  • Hanna GJ; Merck, Kenilworth, NJ, USA.
  • Jefferys R; Treatment Action Group, New York, NY, USA.
  • Johnston R; amfAR, New York, NY, USA.
  • Kuritzkes D; Division of Infectious Diseases, Brigham and Women's Hospital, Cambridge, MA, USA.
  • Li JZ; Division of Infectious Diseases, Brigham and Women's Hospital, Cambridge, MA, USA.
  • Likhitwonnawut U; AVAC: Global Advocacy for HIV Prevention, New York, NY, USA.
  • van Lunzen J; ViiV Healthcare, Brentford, UK.
  • Martinez-Picado J; AIDS Research Institute IrsiCaixa, Barcelona, Spain; Catalan Institution for Research and Advanced Studies, Barcelona, Spain; University of Vic-Central University of Catalonia, Barcelona, Spain.
  • Miller V; Forum for Collaborative Research, Washington, DC, USA.
  • Montaner LJ; The Montaner Laboratory, The Wistar Institute, Philadelphia, PA, USA.
  • Nixon DF; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medical College, New York City, NY, USA.
  • Palm D; Global HIV Prevention, and Treatment Clinical Trials Unit, University of North Carolina, Chapel Hill, NC, USA.
  • Pantaleo G; Service Immunology and Allergy, and Swiss Vaccine Research Institute, Centre Hospitalier Universitaire, Lausanne, Switzerland.
  • Peay H; Research Triangle Institute, Research Triangle Park, NC, USA.
  • Persaud D; Pediatrics Infectious Disease, School of Medicine, University of North Carolina, Chapel Hill, NC, USA.
  • Salzwedel J; AVAC: Global Advocacy for HIV Prevention, New York, NY, USA.
  • Salzwedel K; National Institute of Allergy and Infectious Diseases, Fishers ln Rockville, MD, USA.
  • Schacker T; Division of Infectious Disease and International Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Sheikh V; Division of Antiviral Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Søgaard OS; Department of Infectious Diseases, Aarhus University, Aarhus, Denmark.
  • Spudich S; Department of Neurology, Yale University, New Haven, CT, USA.
  • Stephenson K; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Sugarman J; Berman Institute of Bioethics, University of North Carolina, Chapel Hill, NC, USA.
  • Taylor J; Collaboratory for AIDS Researchers for Eradication, University of North Carolina, Chapel Hill, NC, USA.
  • Tebas P; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Tiemessen CT; Cell Biology Research Laboratory, Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Tressler R; National Institute of Allergy and Infectious Diseases, Fishers ln Rockville, MD, USA.
  • Weiss CD; Division of Antiviral Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Zheng L; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Robb ML; US Military HIV Research Program, Henry Jackson Foundation, Bethesda, MD, USA.
  • Michael NL; US Military HIV Research Program, Henry Jackson Foundation, Bethesda, MD, USA.
  • Mellors JW; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Deeks SG; School of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Walker BD; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA.
Lancet HIV ; 6(4): e259-e268, 2019 04.
Article en En | MEDLINE | ID: mdl-30885693
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Privación de Tratamiento / Antirretrovirales Tipo de estudio: Guideline / Prognostic_studies Aspecto: Ethics Límite: Humans Idioma: En Revista: Lancet HIV Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Privación de Tratamiento / Antirretrovirales Tipo de estudio: Guideline / Prognostic_studies Aspecto: Ethics Límite: Humans Idioma: En Revista: Lancet HIV Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos